Moneycontrol PRO
Open App
you are here: HomeNewsPharma
pharma
Jump to
  • IT stocks a must for a high-quality portfolio, says Marcellus’ Mukherjea Sep 14, 2022 03:30 PM IST

    IT stocks a must for a high-quality portfolio, says Marcellus’ Mukherjea

    “If you don’t have an IT company (in your portfolio), it’s like having a portfolio in the industrial revolution that doesn’t have steam engine technology,” says Mukherjea

  • Zydus acquires rights to market MonoFerric injection in India, Nepal from Pharmacosmos A/S of Denmark Sep 09, 2022 02:13 PM IST

    Zydus acquires rights to market MonoFerric injection in India, Nepal from Pharmacosmos A/S of Denmark

    MonoFerric is indicated for the treatment of iron deficiency in adult patients when oral iron preparations are ineffective or cannot be used or where there is a clinical need to deliver iron rapidly, the company said in a regulatory filing.

  • Stock Market Live: Why cement shares surged amid market weakness; Indigo, Blue Star & Zydus in focus | Morning Trade Sep 08, 2022 08:22 AM IST

    Stock Market Live: Why cement shares surged amid market weakness; Indigo, Blue Star & Zydus in focus | Morning Trade

    European bourses close lower as investors continued to dwell on the recessionary outlook in the region and as inflationary pressures continue to grow. Stoxx 600 ended the day 0.4% lower. Stock in the spotlight today - InterGlobe Aviation, Blue Star, Zydus Lifesciences and Capacite Infra We also explore the key reasons responsible for the pharma sector’s underperformance.

  • Stock Market Live: Will Nifty see a new wave of selling? | Markets with Santo & CJ Sep 07, 2022 08:49 AM IST

    Stock Market Live: Will Nifty see a new wave of selling? | Markets with Santo & CJ

    Nifty 50 and Sensex have made a tentative start to the week in the past two sessions making investors jittery. Watch as CJ discusses what lies in store for Nifty 50 and what are the crucial levels you need to track in the coming days for your trade. Plus his thoughts on IndusInd Bank, Tata Steel, and BEML.

  • Stock Market Live: Why investors are cautious on pharma sector| InterGlobe, Paytm & Syngene in focus | Morning Trade Sep 07, 2022 08:13 AM IST

    Stock Market Live: Why investors are cautious on pharma sector| InterGlobe, Paytm & Syngene in focus | Morning Trade

    European markets close marginally higher as investors continued to assess recession risks in the region. Stoxx 600 ended with gains of 0.2%, and the majority of sectors and all major bourses are in the green. Stocks in the spotlight today - InterGlobe Aviation, Hatsun Agro, Syngene International and Astral. We also explore the key reasons for the pharma sector’s underperformance.

  • Dolo 650 maker Micro Labs rejects allegations of Rs 1,000 crore worth freebies to doctors Aug 21, 2022 05:55 PM IST

    Dolo 650 maker Micro Labs rejects allegations of Rs 1,000 crore worth freebies to doctors

    The Supreme Court on Thursday was told by an NGO that the Central Board of Direct Taxes has accused the Bengaluru-based drug firm of distributing Rs 1,000 crore freebies to doctors for prescribing its 650 mg tablets.

  • AstraZeneca India receives DCGI's nod to market drug treating breast cancer Aug 19, 2022 05:45 PM IST

    AstraZeneca India receives DCGI's nod to market drug treating breast cancer

    The Drugs Controller General of India (DCGI) has approved Lynparza (Olaparib) as a monotherapy for the treatment of adult patients with early breast cancer.

  • Divi's Q1 Poll| Solid profit, revenue growth on cards, but costs could dent margin Aug 12, 2022 10:43 AM IST

    Divi's Q1 Poll| Solid profit, revenue growth on cards, but costs could dent margin

    Shares of Divi's have been under pressure this fiscal, as margin are weighed down by input cost, China lockdowns, and a spike in freight rates.

  • These stocks will be either winners or losers due to rupee weakening Jul 19, 2022 04:22 PM IST

    These stocks will be either winners or losers due to rupee weakening

    Information technology, pharmaceutical and textile industries may benefit because they are net exporters. Oil and gas and aviation are some of the sectors which will have a negative impact on the rupee weakness.

  • Ideas for Profit | Uflex: Resilient pharma & FMCG demand to sustain growth? Jul 08, 2022 08:43 PM IST

    Ideas for Profit | Uflex: Resilient pharma & FMCG demand to sustain growth?

    Uflex is well-positioned to catapult into the next growth phase given resilient end-markets and sustainable manufacturing initiatives. MC Pro suggests investors to consider it as a long-term buying opportunity. Should you buy? Watch the video to find out.

  • Pharma businesses with strong quality compliance to emerge stronger as pandemic impact decreases: Ajay Piramal Jul 08, 2022 03:22 PM IST

    Pharma businesses with strong quality compliance to emerge stronger as pandemic impact decreases: Ajay Piramal

    The company's pharma vertical is expected to have nearly 15 per cent CAGR revenue growth across businesses in the medium to long-term, Piramal said.

  • India Inc’s hiring appetite to grow in Q2; IT, FMCG, Education among key sectoral drivers: TeamLease Jul 06, 2022 04:10 PM IST

    India Inc’s hiring appetite to grow in Q2; IT, FMCG, Education among key sectoral drivers: TeamLease

    Attrition continues to be high in sectors like IT (22%), educational services (13.11%), healthcare and pharma (12.25%) and ecommerce (11.04%) .

  • PLI scheme can add 4% to GDP annually, says new report Jul 05, 2022 05:30 PM IST

    PLI scheme can add 4% to GDP annually, says new report

    So far, the scheme has seen maximum response from the electronics, auto components, and pharma sectors, according to Emkay Investment Managers

  • Ideas For Profit | Sastasundar Ventures: Strong cash flow, Flipkart deal to cap stock price erosion? Jun 24, 2022 05:49 PM IST

    Ideas For Profit | Sastasundar Ventures: Strong cash flow, Flipkart deal to cap stock price erosion?

    Sastasundar Ventures' stock has plunged over 50 percent from its all-time high in November’21, even though the business remains largely unaffected by ongoing market condition. MC Pro suggests growth outlook appears very promising from a long-term standpoint. Watch the video to find out why.

  • Ideas For Profit | Gland Pharma trades at a discount to Syngene & Divi’s; Enough triggers to invest? Jun 23, 2022 07:19 PM IST

    Ideas For Profit | Gland Pharma trades at a discount to Syngene & Divi’s; Enough triggers to invest?

    With the rising prevalence of chronic diseases and growth of biologics, MC Pro recommends holding Gland Pharma. Post the recent correction and downward adjustments in estimates, Gland Pharma is trading at 17x EV/EBITDA for FY24e. Here’s why it makes for a good investment bet.

  • Sun Pharma gets double thumbs-up from analysts at Jefferies India Jun 20, 2022 08:58 AM IST

    Sun Pharma gets double thumbs-up from analysts at Jefferies India

    The brokerage expects Sun Pharma growth to be driven by its speciality portfolio and India market from hereon

  • Bajar Gupshup | Indices nosedive; Sensex tanks more than 1,000 points, Nifty ends at 16,202 Jun 10, 2022 04:38 PM IST

    Bajar Gupshup | Indices nosedive; Sensex tanks more than 1,000 points, Nifty ends at 16,202

    Sensex tanked more than 1,000 points to close at 54,303 and Nifty ended at 16,202. All sectoral and broader indices came under pressure with Nifty Bank, IT, Financial Services ending up as the biggest losers.

  • Bajar Gupshup | Benchmarks settle near day's high; IT, oil and gas shine Jun 02, 2022 05:52 PM IST

    Bajar Gupshup | Benchmarks settle near day's high; IT, oil and gas shine

    Benchmark indices ended the session on a positive note with the Sensex gaining 437 points, and the Nifty adding 105 points. Reliance surged over three percent to close at one-month high. The midcap index ended flat while the small-cap index closed with gains of half a percent.

  • Manufacturing sops in green energy, pharma and battery sectors to boost capital expenditure : Report Jun 01, 2022 08:51 PM IST

    Manufacturing sops in green energy, pharma and battery sectors to boost capital expenditure : Report

    According to a report released on Wednesday, capital investment in the manufacturing sector is on track to increase as a result of overwhelming reactions to the government's production-linked incentive schemes, particularly in the lithium-ion battery, pharmaceutical, and solar module segments.

  • Markets with Santo & CJ | What early 2000s can tell you about bear market rallies? May 30, 2022 02:45 PM IST

    Markets with Santo & CJ | What early 2000s can tell you about bear market rallies?

    Coming up on markets with #SantoAndCJ at 3 PM | #ICYMI What early 2000s can tell you about bear market rallies? Also, Santo & CJ’s take on DLF, 3M India, Atul Auto, Sudarshan Chemicals and Granules India.

  • Markets with Santo and CJ | M&M, JSW Steel, Tata Power, TCNS Clothing, and Nykaa in focus May 30, 2022 08:38 AM IST

    Markets with Santo and CJ | M&M, JSW Steel, Tata Power, TCNS Clothing, and Nykaa in focus

    Nifty 50 closed above the 20 DMA on Friday and is likely to cross the 16,400 level. Also, know why Santo and CJ are tracking M&M, JSW Steel, Tata Power, TNS Clothing, and Nykaa.

  • Bajar Gupshup | Indices end with robust gains; IT, banking, auto & FMCG sectors top gainers May 27, 2022 05:08 PM IST

    Bajar Gupshup | Indices end with robust gains; IT, banking, auto & FMCG sectors top gainers

    Benchmark indices ended higher for the second consecutive day on May 27. At close, the Sensex was up 632.13 points or 1.17% at 54,884.66, and the Nifty was up 182.30 points or 1.13% at 16,352.50. Here’s the round-up of all the day’s action with Yatin Mota.

  • Bajar Gupshup | Nifty, Sensex end higher; IT, power and bank stocks rally May 26, 2022 05:30 PM IST

    Bajar Gupshup | Nifty, Sensex end higher; IT, power and bank stocks rally

    After seeing a downtrend for three straight days, the Indian equity benchmarks ended higher on May 26 as buying in metal, IT, power, realty and banking stocks supported the market. Here’s a round-up of all the day’s action with Yatin Mota.

  • After ban on wheat exports, will the government restrict non-basmati rice exports too? May 26, 2022 02:56 PM IST

    After ban on wheat exports, will the government restrict non-basmati rice exports too?

    India's price monitoring committee will meet and hold discussions on major food products after the government banned wheat exports. As per sources, non-basmati rice exports might also be restricted. Will this lead to a rise in the prices of rice? Manisha Gupta brings you the details

  • Bajar Gupshup | Markets tank for third consecutive session amid selloff in IT, metal stocks May 25, 2022 04:58 PM IST

    Bajar Gupshup | Markets tank for third consecutive session amid selloff in IT, metal stocks

    Indian equity benchmark ended lower for the third consecutive day today, pulled down by a selloff in information technology, metal and realty names. At close, the Sensex was down 303.35 points, or 0.56 percent, at 53,749.26, and the Nifty was down 99.40 points, or 0.62 percent, at 16,025.80. Here's a wrap of today's market action with Yatin Mota.

Sections
ISO 27001 - BSI Assurance Mark